Glaukos Corporation Profile Avatar - Palmy Investing

Glaukos Corporation

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro…

Medical - Devices
US, San Clemente [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Glaukos Corporation mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of GKOS's Analysis
CIK: 1192448 CUSIP: 377322102 ISIN: US3773221029 LEI: - UEI: -
Secondary Listings
GKOS has no secondary listings inside our databases.